Your browser doesn't support javascript.
loading
Combination venetoclax and selinexor effective in relapsed refractory multiple myeloma with translocation t(11;14).
Nguyen, Nina; Chaudhry, Sana; Totiger, Tulasigeri M; Diaz, Robert; Roberts, Evan; Montoya, Skye; Pardo, Gabriel; Pardo, Alejandro; Afaghani, Jumana; Affer, Maurizio; Jahn, Jacob; Bradley, Terrence; Maura, Francesco; Kazandjian, Dickran; Bilbao, Daniel; Chapman, Jennifer; Landgren, Ola; Hoffman, James; Taylor, Justin.
Affiliation
  • Nguyen N; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Chaudhry S; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Totiger TM; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Diaz R; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Roberts E; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Montoya S; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Pardo G; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Pardo A; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Afaghani J; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Affer M; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Jahn J; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Bradley T; Leukemia Program, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Maura F; Myeloma Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Kazandjian D; Myeloma Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Bilbao D; Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, Miami, FL, USA.
  • Chapman J; Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Landgren O; Myeloma Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Hoffman J; Myeloma Division, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. j.hoffman4@med.miami.edu.
  • Taylor J; Leukemia Program, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA. jxt1091@miami.edu.
NPJ Precis Oncol ; 6(1): 73, 2022 Oct 19.
Article in En | MEDLINE | ID: mdl-36261486
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Precis Oncol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Precis Oncol Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom